key: cord-0765110-c0f1uaad authors: Mortazavi, SMJ; Kefayat, Amirhosein; Cai, Jing title: Low dose radiation as a treatment for COVID‐19 pneumonia: a threat or real opportunity? date: 2020-07-03 journal: Med Phys DOI: 10.1002/mp.14367 sha: 1a24d1b606d5b5686d0cc9605066055575f099f7 doc_id: 765110 cord_uid: c0f1uaad Low‐dose radiation is known to induce anti‐inflammatory responses and has been historically used for treating infectious diseases such as pneumonia. As the outbreak of COVID‐19 continues globally and effective treatment methods are lacking, low‐dose radiation has drawn increasing attention recently. While some are optimistic about the clinical adoption of low‐dose radiation for the treatment of COVID‐19, others have significant concerns about its effectiveness and safety. This is the premise debated in this month's Point/Counterpoint. radiation for COVID-19 treatment, and most of them are currently recruiting patients. Hopefully, results from these clinical trials will be available soon for further and more informative discussions. FOR THE PROPOSITION: SMJ Mortazavi, Ph.D. It has long been known that low-dose radiation can induce anti-inflammatory responses due to its potential for inducing polarization of both M1 and M2 macrophage phenotypes 2 . Historically, lowdose radiation was successfully used for treatment of infectious diseases such as pneumonia 3 . The concept of using low dose radiation therapy (LDRT) for COVID-19 pneumonia was first introduced by a group of Iranian and American scientists in March 2020 4 . Subsequently, Canadian, Spanish, American, German and more recently French scientists also confirmed the potential efficacy of LDRT for COVID-19 pneumonia. These reports have mainly focused on the anti-inflammatory and immunomodulatory effects of LDRT and suggested that lung doses ranging 100 mGy-1000 mGy could be beneficial for treatment of severe pneumonia in COVID-19 patients. In less than a month, the report by Ghadimi-Moghadam et al. 4 received attention not only for introducing LDRT as a treatment method for pneumonia in COVID-19 patients but for noting the key disadvantages of other treatment methods such as using antiviral drugs. Rödel et al. 5 in their paper published recently state "SARS-COV-2 is an RNA virus with an expected moderate to high mutation rate …. 6 . In addition, as discussed in a recent manuscript 4 Dilucca et al. 7 in their paper published recently in the Viruses Journal highlight the importance of LDRT and address the potential problems associated with the widespread use of different antiviral drugs "as discussed in a recent paper 4 Furthermore, low doses of ionizing radiation can combat the cytokine storm in severe pneumonia associated with COVID-19 pulmonary damage. The rapid responses of pneumonia patients to LDRT suggest that apoptosis of cytokine-producing infiltrating cells might be a substantial component as This article is protected by copyright. All rights reserved symptoms started to improve within hours. In addition, autopsies have revealed hundreds of micro thrombi in the lungs of infected people. When the blood clots grow larger in size they can embolize to the brain or heart, causing a stroke or heart attack 8 . Thus, scientists hypothesized that severe hematological alterations can be involved in some of these abnormalities 8 . As oxidative stress plays a key role in the clotting cascade through multiple pathways including enhanced formation of isoprostanes 9 , it might be hypothesized that LDRT would also reduce or prevent the blood clotting through reducing oxidative stress. Recently, the potential of different therapeutic approaches for COVID-19 pneumonia treatment has been discussed. Some researchers have suggested LDRT for COVID-19 treatment. They mostly relied on previous studies that reported positive effects of radiation beams on the different types of pneumonia. However, these publications belong to the early 20 th century and a significant lack of satisfactory scientific reliability is apparent in them. For instance, most of these studies on pneumonia patients had case report format and modern randomization of subjects, and blinded investigation principles weren't used in their methods. Also, their animal experiments contained obvious limitations and pitfalls 10 . Thus, these observations which support the effectiveness of LDRT for pneumonia treatment aren't reliable and need re-assessment with the latest scientific principles. Many researchers believe that the anti-inflammatory effect of LDRT is the main mechanism of action by which LDRT treat pneumonia. Although LDRT exhibits anti-inflammatory effects, it is currently used just for controlling local and limited inflammations 11 . However, the main reason of COVID-19 patients' death is cytokine storm which is an extensive systemic inflammatory response 12 . Therefore, the anti-inflammatory effect of LDRT may not be strong enough for inhibiting the SARS- We addressed this challenging issue in our paper 4 . Other researchers also believe that considering the available data and the mechanism proposed for LDRT, a single dose of 0.3-0.5 Gy would be beneficial for COVID-19 patients with severe symptoms who experience the cytokine storm 18 . He also believes that the anti-inflammatory effects of LDRT may lead to suppression of immune responses against the invading pathogen. Substantial evidence indicates that LDRT doesn't cause either suppression or over-activation of the immune system but plays a critical role in both maintaining and optimizing the immune system. Optimizing the immune system by LDRT can help protect against COVID-19 and mitigates acute respiratory distress syndrome (ARDS). Moreover, he claims that LDRT can lead to increase in uptake, activation, transcription, and spread of some viruses. Since there are no data about SARS-CoV-2, this claim is thoroughly based on speculations and presumptions. Regarding other viruses, radiotherapy has been proposed as a costeffective treatment for patients infected with the Ebola virus 19 . In addition, some studies have introduced radioimmunotherapy (RIT) as the most promising backbone strategy for eradication of human immunodeficiency virus (HIV) 20 . My PCP colleague also claims that apoptosis by LDRT might accelerate the spread of the virus. Although apoptosis by low-dose radiation is reported in some cancer cells, accelerating the spread of a virus by this phenomenon is just a speculation. In normal tissues, low-dose radiation can lead to beneficial effects "Low-dose radiation induces apoptosis of tumor cells and has numerous beneficial effects on normal tissues, including radiation homeostasis and adaptive response 21 This article is protected by copyright. All rights reserved Moreover, Dr. Mortazavi mentioned the increased risk of thrombosis formation in COVID-19 patients and suggested that LDRT may reduce or prevent blood clotting in these patients by reducing oxidative stress. However, several studies have demonstrated the promoting effects of LDRT on oxidative stress through increasing free radicals production 22, 23 . On the other hand, there are some supporting findings about the procoagulant changes after irradiation with different radiation qualities and doses for instance, induction of endothelial cells death and loss of their integrity which separates blood clotting factors from exposure to subendothelial prothrombotic extracellular matrix components 24 . Taking together, it seems LDRT not only cannot decrease the risk of coagulopathy in COVID-19 patients but also may promote clot formation. Numerous studies on developing vaccines and anti-viral drugs for COVID-19 prevention and treatment are ongoing. It is somehow apparent that using anti-viral drugs and vaccines for COVID-19 treatment would be more acceptable for patients in comparison with ionizing radiations even in low dose form. Therefore, further achievements in these fields like approving remdesivir for COVID-19 treatment 25 may causes to forget employing LDRT for COVID-19 treatment forever. There is no conflict of interest to declare. Low-Dose Whole-Lung Radiation for COVID-19 Accepted Article This article is protected by copyright. All rights reserved 2 Radiotherapy treatment of human inflammatory diseases and conditions: optimal dose How radiotherapy was historically used to treat pneumonia: could it be useful today? The Yale journal of biology and medicine COVID-19 Tragic Pandemic: Concerns over Unintentional "Directed Accelerated Evolution" of Novel Coronavirus (SARS-CoV-2) and Introducing a Modified Treatment Method for ARDS Low-dose radiation therapy for COVID-19 pneumopathy: what is the evidence? Strahlentherapie und Onkologie Exposure to mercuric chloride induces developmental damage, oxidative stress and immunotoxicity in zebrafish embryos-larvae Codon Usage and Phenotypic Divergences of SARS-CoV-2 Genes A mysterious blood-clotting complication is killing coronavirus patients Platelet oxidative stress and thrombosis Low dose radiation therapy for COVID-19 pneumonia: a double-edged sword Anti-inflammatory effects of low-dose radiotherapy The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality Into the eye of the cytokine storm Therapeutic doses of irradiation activate viral transcription and induce apoptosis in HIV-1 infected cells Ionizing radiation activates late herpes simplex virus 1 promoters via the p38 pathway in tumors treated with oncolytic viruses Radiotherapy-induced reactivation of neurotrophic human herpes viruses: Overview and management Ionizing radiation modulates the spread of an apathogenic rabies virus in mouse brain Low dose radiation therapy as a potential life saving treatment for COVID-19-induced acute respiratory distress syndrome (ARDS). Radiotherapy and Oncology Radiotherapy is an appropriate treatment to consider for patients infected with the Ebola virus The potential of radioimmunotherapy as a new hope for HIV patients Low-dose radiation-induced apoptosis in human leukemia K562 cells through mitochondrial pathways Low-dose ionizing radiation exposure, oxidative stress and epigenetic programing of health and disease Low-dose irradiation promotes persistent oxidative stress and decreases self-renewal in hematopoietic stem cells Aerts AJC, sciences ml. Pathological effects of ionizing Amirhosein Kefayat wants to thank Dr. Fatemeh Ghahremani for her advice during this Point/Counterpoint. This article is protected by copyright. All rights reserved